Sitemap

STADA achieved strong results in the first half of 2019

More...

Apatin Brewery Appealing For Responsible Alcohol Consumption

Within the ‘When I drink I don’t...

EU Awards One Million EUR In Grants For COVID Recovery In Tourism Sector

“#EUzaTebe – For Cultural Heritage and Tourism”...

Mlekoprodukt To Export To The EU And China Markets

The company Mlekoprodukt, which operates within the...

News

Agreement On Normalisation Of Economic Relations Between Belgrade And Pristina Signed

President of Serbia Aleksandar Vucic and Prime Minister of the Provisional Institutions of Kosovo Avdullah Hoti signed an Agreement...

Montenegro Election: First Projections Point To A Tight Race

In Montenegro, the ruling DPS was nearly neck-and-neck with its main rivals, according to early and incomplete projections of...

EU Awards One Million EUR In Grants For COVID Recovery In Tourism Sector

“#EUzaTebe – For Cultural Heritage and Tourism” project has awarded one million euros for 120 projects aimed at supporting...

UNDP And Embassy Of Slovakia Present Feasibility Study On Use Of Thermosolar Energy

The Mayor of Belgrade, Zoran Radojičić, met with the Ambassador of Slovakia to Serbia, H.E. Fedor Rosocha and Resident...

The EU Does Not Recognize Belarus Election Results

Members of the European Council held a video conference, at which they discussed the situation after the presidential elections...

With record sales growth of 11 per cent in the first half of this year, Stada’s performance is well above the industry average.

The Stada Group, within which Hemofarm operates, continues to grow significantly, achieving strong results in the first half of 2019. Reported consolidated sales increased 11 per cent in the first half of 2019 to 1.26 billion Euros (2018: Euro 1.14 billion).

On this occasion, Peter Goldschmidt, CEO of Stada, said: “We are particularly pleased that Stada is experiencing strong growth in both our core segments – branded products / OTC and generics, including pharmaceutical specialities.”

Stada saw strong sales growth and significant market share gains in key European markets, including Germany, the United Kingdom, Italy, Spain and France. The company also recorded good growth in the areas of northern and eastern Europe as well as in Asia / the Middle East. In the first half of this year, Stada continued to invest in production capacity and supply chain. As part of the overall optimization of the production network, the company recently opened a new factory in Vietnam with a capacity of four billion tablets. This production site meets the latest GMP EU quality standards so that Stada can supply the European market from Vietnam in the future.

Related Articles

Sanda Savić, Director of Communications at Hemofarm

Success is Unlocked By Words & Confirmed By Images

Hemofarm is a regional leader in the pharmaceutical industry, with record volumes of production, a record number of products and record sales, but it...

Ronald Seeliger, President of the German-Serbian Chamber of Commerce

Strong Bonding

Many German companies have been investing repeatedly in Serbia, expanding their production capacities, creating additional jobs and growing year on year. This commitment and...

Marina Mitić Jekić, HR Director, STADA CEE Region and Hemofarm a.d.

Dedication is Always Rewarded With Trust

As of this May, the Faculty of Technology Novi Sad has launched an event that it will organise annually entitled “Hemofarm Day”, which emerged...

Belgrade Youth Fair 2019

18-19 April 2019, Metropol Palace Hotel

Hemofarm – Repeating our records and raising the bar

Hemofarm, a regional leader in the pharmaceutical industry, will finish this year successfully: the company has confirmed last year's record in the production of...

International Award For Hemofarm Foundation Campaign

‘Don’t let it Burst’, the campaign of Hemofarm Foundation for prevention of high blood pressure, was awarded the Silver Drum award in the category...

Hemofarm at the UN debate: More than half of our employees are women

Hemofarm is the only company from Serbia and this part of Europe that has had the opportunity to participate in this year's UN Debate...

Dr Ronald Seeliger, President of AHK Serbia, CEO of Hemofarm

Profound Reforms Cannot Be Swift But Well Considered

Serbia is in the process of overall transformation, and this kind of total makeover takes time, requires expertise and seeks patience. It is of...